Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart McPherson

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Translational Behavioral Medicine|May 24, 2019
Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative studyKate Hallsworth, Stephan U Dombrowski, Stuart McPherson, et al.
Idcases|March 21, 2023
Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infectionJennifer Gallacher, Yusri Taha, Ana da Silva Filipe, et al.
Diseases of the Colon and Rectum|March 10, 2006
Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrheaStuart McPherson, Colin J Rees, Richard Ellis, et al.
BMJ Open Gastroenterology|June 30, 2025
Feasibility of a digital lifestyle intervention (VITALISE) to support weight loss in patients with MASLD in routine secondary careLeah Avery, Hollie Smith, Rebecca Livingston, et al.
Frontline Gastroenterology|August 26, 2017
Improving access to treatment for patients with chronic hepatitis C through outreachAhmed Mohamed Elsharkawy, Carolyn Miller, Andrea Hearn, et al.
Journal of Hepatology|January 22, 2014
Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Elsbeth Henderson, Alastair D Burt, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?Stuart McPherson, Quentin M Anstee, Elsbeth Henderson, et al.
Journal of Medical Internet Research|January 15, 2021
Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention MappingKate Hallsworth, Stuart McPherson, Quentin M Anstee, et al.
Gut|August 31, 2010
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Stephen F Stewart, Elsbeth Henderson, et al.
Alimentary Pharmacology & Therapeutics|June 11, 2024
How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease?Stuart McPherson, Jessica K Dyson, Laura Jopson, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Translational Behavioral Medicine|May 24, 2019
Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative studyKate Hallsworth, Stephan U Dombrowski, Stuart McPherson, et al.
Idcases|March 21, 2023
Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infectionJennifer Gallacher, Yusri Taha, Ana da Silva Filipe, et al.
Diseases of the Colon and Rectum|March 10, 2006
Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrheaStuart McPherson, Colin J Rees, Richard Ellis, et al.
BMJ Open Gastroenterology|June 30, 2025
Feasibility of a digital lifestyle intervention (VITALISE) to support weight loss in patients with MASLD in routine secondary careLeah Avery, Hollie Smith, Rebecca Livingston, et al.
Frontline Gastroenterology|August 26, 2017
Improving access to treatment for patients with chronic hepatitis C through outreachAhmed Mohamed Elsharkawy, Carolyn Miller, Andrea Hearn, et al.
Journal of Hepatology|January 22, 2014
Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Elsbeth Henderson, Alastair D Burt, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?Stuart McPherson, Quentin M Anstee, Elsbeth Henderson, et al.
Journal of Medical Internet Research|January 15, 2021
Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention MappingKate Hallsworth, Stuart McPherson, Quentin M Anstee, et al.
Gut|August 31, 2010
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Stephen F Stewart, Elsbeth Henderson, et al.
Alimentary Pharmacology & Therapeutics|June 11, 2024
How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease?Stuart McPherson, Jessica K Dyson, Laura Jopson, et al.
Pageof 11